BMO Capital analyst Keith Bachman downgraded DXC Technology to Market Perform from Outperform and lowered his price target for the shares to $48 from $60. The company's June quarter results heightened concerns around its ability generate "meaningful" free cash flow, grow revenues given the weight of mix and ongoing cost cutting, and management's comp structure "that is not aligned to shareholder interest," Bachman tells investors in a research note. Further, the analyst is skeptical that DXC could go private or spin some businesses to create shareholder value.